Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Slipicevic · SciRah

Researcher profile · Semantic Scholar

A. Slipicevic

Share profile

A. Slipicevic — researcher profile on SciRah

h-index: 18
Works: 54
Citations: 1,206

Most-cited papers

High Expression of Wee1 Is Associated with Poor Disease-Free Survival in Malignant Melanoma: Potential for Targeted Therapy
G. Magnussen, R. Holm, E. Emilsen, Anne Katrine Ree Rosnes +2 more
2012PLoS ONE146 citations Open access
Semantic Scholar
Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma.
B. Davidson, R. Hadar, Anat Schlossberg, T. Sternlicht +6 more
2008Human Pathology111 citations
Semantic Scholar
Expression of activated Akt and PTEN in malignant melanomas: relationship with clinical outcome.
A. Slipicevic, R. Holm, M. Nguyen, P. Bøhler +2 more
2005American Journal of Clinical Pathology102 citations Open access
Semantic Scholar
Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells
Marie R. Webster, Mai Xu, Kathryn A. Kinzler, Amanpreet Kaur +19 more
2014Pigment Cell & Melanoma Research86 citations Open access
Semantic Scholar
The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells
A. Slipicevic, Kjersti Jørgensen, M. Skrede, Anne Katrine Ree Rosnes +3 more
2008BMC Cancer78 citations Open access
Semantic Scholar
Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions.
A. Slipicevic, A. Holth, Ellen Hellesylt, C. Tropé +2 more
2014Gynecologic Oncology75 citations
Semantic Scholar
Pax-5 expression in nonhematopoietic tissues.
E. Torlakovic, A. Slipicevic, C. Robinson, J. Decoteau +4 more
2006American Journal of Clinical Pathology58 citations Open access
Semantic Scholar
Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells
A. Green, Petra Marttila, N. Kiweler, Christina Chalkiadaki +30 more
2023Nature Metabolism55 citations Open access
Semantic Scholar
Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to Melflufen
Juho J Miettinen, R. Kumari, G. A. Traustadottir, Maiju-Emilia Huppunen +14 more
2021Cancers51 citations Open access
Semantic Scholar
Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma
G. Magnussen, E. Emilsen, Karianne Giller-Fleten, Birgit Engesæter +4 more
2015BMC Cancer48 citations Open access
Semantic Scholar
Fli-1 expression in malignant melanoma.
E. Torlakovic, A. Slipicevic, V. A. Flørenes, R. Chibbar +2 more
2008Histology and Histopathology38 citations
Semantic Scholar
KIT in Melanoma: Many Shades of Gray
A. Slipicevic, M. Herlyn
2015Journal of Investigative Dermatology37 citations Open access
Semantic Scholar
Phorbol ester phorbol-12-myristate-13-acetate promotes anchorage-independent growth and survival of melanomas through MEK-independent activation of ERK1/2.
Kjersti Jørgensen, M. Skrede, V. Cruciani, S. Mikalsen +2 more
2005Biochemical and Biophysical Research Communications - BBRC37 citations
Semantic Scholar
Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival
A. Slipicevic, R. Holm, E. Emilsen, A. K. Ree Rosnes +3 more
2012BMC Cancer32 citations Open access
Semantic Scholar
Biological effects induced by insulin‐like growth factor binding protein 3 (IGFBP‐3) in malignant melanoma
Geir Frode Oy, A. Slipicevic, B. Davidson, Ragnar Solberg Faye +2 more
2010International Journal of Cancer23 citations Open access
Semantic Scholar
Narrowing the knowledge gaps for melanoma
A. Slipicevic, M. Herlyn
2012Upsala Journal of Medical Sciences22 citations Open access
Semantic Scholar
Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells
Xiao-Ran Li, Jie Lu, Quan-Cheng Kan, Xiao-Li Li +13 more
2017Scientific Reports19 citations Open access
Semantic Scholar
Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis
A. Slipicevic, G. F. Øy, Anne Katrine Ree Rosnes, Øystein Stakkestad +4 more
2013Cancer Biology & Therapy19 citations Open access
Semantic Scholar
Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.
A. Slipicevic, G. F. Øy, Inger Cecilie Askildt, A. Holth +3 more
2009Human Pathology18 citations
Semantic Scholar
MX2 is a novel regulator of cell cycle in melanoma cells
Marina Juraleviciute, J. Pozniak, J. Nsengimana, M. Harland +10 more
2019Pigment Cell & Melanoma Research17 citations Open access
Semantic Scholar
Up-regulation of multidrug resistance protein MDR1/ABCB1 in carfilzomib-resistant multiple myeloma differentially affects efficacy of anti-myeloma drugs.
K. Byrgazov, Marianne Kraus, A. Besse, A. Slipicevic +3 more
2020Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis16 citations Open access
Semantic Scholar
MX2 mediates establishment of interferon response profile, regulates XAF1, and can sensitize melanoma cells to targeted therapy
Marina Juraleviciute, J. Nsengimana, J. Newton-Bishop, Gert‐Jan Hendriks +1 more
2021Cancer Medicine13 citations Open access
Semantic Scholar
Expression of CDK1Tyr15, pCDK1Thr161, Cyclin B1 (Total) and pCyclin B1Ser126 in Vulvar Squamous Cell Carcinoma and Their Relations with Clinicopatological Features and Prognosis
Zhi-Hui Wang, A. Slipicevic, M. Førsund, C. Tropé +2 more
2015PLoS ONE12 citations Open access
Semantic Scholar
MiR-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinoma.
D. Nymoen, A. Slipicevic, A. Holth, E. Emilsen +5 more
2016Human Pathology11 citations Open access
Semantic Scholar
Melflufen, a peptide‐conjugated alkylator, is an efficient anti‐neo‐plastic drug in breast cancer cell lines
Alexander Schepsky, Gunnhildur Asta Traustadottir, J. Jóelsson, S. Ingthorsson +8 more
2020Cancer Medicine10 citations Open access
Semantic Scholar
Targeting aggressive osteosarcoma with a peptidase-enhanced cytotoxic melphalan flufenamide
K. Byrgazov, C. Anderson, B. Salzer, E. Bozsaky +8 more
2020Therapeutic Advances in Medical Oncology9 citations Open access
Semantic Scholar
Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma
V. A. Flørenes, E. Emilsen, H. Dong, M. Førsund +2 more
2015Cancer Medicine9 citations Open access
Semantic Scholar
Novel Peptide-drug Conjugate Melflufen Efficiently Eradicates Bortezomib-resistant Multiple Myeloma Cells Including Tumor-initiating Myeloma Progenitor Cells
K. Byrgazov, A. Besse, Marianne Kraus, A. Slipicevic +3 more
2021HemaSphere8 citations Open access
Semantic Scholar
Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen
A. Gebraad, Roope Ohlsbom, Juho J Miettinen, Promise Emeh +9 more
2022Cells7 citations Open access
Semantic Scholar
Evaluation of CHK1 activation in vulvar squamous cell carcinoma and its potential as a therapeutic target in vitro
Zhi-Hui Wang, M. Førsund, C. Tropé, J. Nesland +2 more
2018Cancer Medicine7 citations Open access
Semantic Scholar
Isolation of melanoma cell subpopulations using negative selection
A. Slipicevic, R. Somasundaram, Katrin Sproesser, M. Herlyn
2014Methods in molecular biology7 citations Open access
Semantic Scholar
The Peptide–Drug Conjugate Melflufen Modulates the Unfolded Protein Response of Multiple Myeloma and Amyloidogenic Plasma Cells and Induces Cell Death
K. Flanagan, R. Kumari, Juho J Miettinen, Staci L Haney +9 more
2022HemaSphere5 citations Open access
Semantic Scholar
Efficacy of melflufen in multiple myeloma with mutated or deleted TP53
K. Acs, Juho J Miettinen, P. Sergeev, T. Heckel +17 more
2025Experimental Hematology & Oncology4 citations Open access
Semantic Scholar
Melphalan flufenamide inhibits osteoclastogenesis by suppressing proliferation of monocytes
K. Byrgazov, T. Lind, A. Rasmusson, Claes R. Andersson +6 more
2021Bone Reports4 citations Open access
Semantic Scholar
Abstract 1843: Melflufen efficacy in multiple myeloma withTP53aberrations
A. Slipicevic, U. Munawar, T. Stühmer, J. Aschan +9 more
2020Experimental and Molecular Therapeutics4 citations
Semantic Scholar
In Vitro and inVivo Activity of Melflufen in Amyloidosis
K. Flanagan, M. Majumder, R. Kumari, Juho J Miettinen +7 more
2019Blood3 citations
Semantic Scholar
Effect of ABCB1 Multidrug Resistance Protein on Efficacy of Anti-Myeloma Drugs in Carfilzomib-Resistant Myeloma Model
K. Byrgazov, Marianne Kraus, A. Besse, A. Slipicevic +3 more
20202 citations Open access
Semantic Scholar
Efficacy of Melflufen in Patients with Relapsed/Refractory Multiple Myeloma and Mutated or Deleted TP53
K. Acs, Juho J Miettinen, P. Sergeev, T. Heckel +16 more
2024medRxiv1 citations Open access
Semantic Scholar
A peptidase-potentiated alkylating agent melflufen is effective anti-neoplastic agent in osteosarcoma
K. Byrgazov, A. Slipicevic, F. Lehmann, T. Lion +2 more
2019Annals of Oncology1 citations Open access
Semantic Scholar
Genotype-Encoded UV Sensitivity in iPSC-Derived Human Melanocytes Reveals MX2 as a Physiological Amplifier of p53/p38-Mediated DNA Damage Signaling
E. Ramírez-Salazar, A. Slipicevic, Marina Juraleviciute, Ling Li +5 more
2026International Journal of Molecular Sciences0 citations Open access
Semantic Scholar
P598: DISRUPTION IN ONE-CARBON METABOLISM THROUGH MTHFD1 INHIBITION AS NOVEL THERAPEUTIC STRATEGY IN CHRONIC LYMPHOCYTIC LEUKEMIA
E. Viry, Chloé Duculty, N. Kiweler, Coralie Pulido +7 more
2023HemaSphere0 citations Open access
Semantic Scholar
PB2071: SENSITIVITY OF MULTIPLE MYELOMA TO MELFLUFEN ASSOCIATES WITH DECREASED P53 ACTIVITY AND ENRICHMENT OF DNA DAMAGE REPAIR PATHWAY GENES
Juho J Miettinen, P. Sergeev, Sadiksha Adhikari, Maiju-Emilia Huppunen +6 more
2023HemaSphere0 citations Open access
Semantic Scholar
P874: DECIPHERING PLASMA CELL HETEROGENEITY AND TUMOR MICROENVIRONMENT IN LIGHT-CHAIN AMYLOIDOSIS USING SINGLE CELL RNA-SEQUENCING
Abhishek Srivastava, R. Kumari, S. Adhikari, P. Sergeev +7 more
2022HemaSphere0 citations Open access
Semantic Scholar
A Potential Role of NK Cells and ABCB9 in Modulating the Response to Melflufen in Multiple Myeloma
P. Sergeev, Sadiksha Adhikari, Juho J Miettinen, Maiju-Emilia Huppunen +6 more
2022Blood0 citations Open access
Semantic Scholar
Single Cell RNA Sequencing Identifies Potential Molecular Indicators of Response to Melflufen in Multiple Myeloma
P. Sergeev, Sadiksha Adhikari, Juho J Miettinen, Maiju-Emilia Huppunen +5 more
2021Blood0 citations Open access
Semantic Scholar
Abstract 5205: Melflufen, a peptide-conjugated alkylator, shows efficacy in breast cancer cell lines
Alexander Schepsky, G. A. Traustadottir, J. Jóelsson, S. Ingthorsson +7 more
2020Experimental and Molecular Therapeutics0 citations
Semantic Scholar
Anti-Myeloma Drug Melflufen Inhibits RANKL-Stimulated Osteoclastogenesis By Suppressing Proliferation of CD14+ Precursor Cells
K. Byrgazov, A. Rasmusson, Claes R. Andersson, M. Berglund +8 more
20200 citations Open access
Semantic Scholar
Abstract C056: MIV-818 stimulates an antitumor immune response in vitro and enhances the effects of pembrolizumab
F. Oberg, K. Tunblad, A. Slipicevic, R. Bethell +1 more
2019Therapeutic Agents: Other0 citations
Semantic Scholar
Aminopeptidase gene expression in myeloma
N. Nupponen, M. Majumder, P. Dowling, J. Lievonen +7 more
2019Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
Abstract B27: Wnt5A-expressing melanoma cells show classical markers of senescence following radiation and therapeutic stress, but retain the ability to metastasize and proliferate at distant sites
Marie R. Webster, Mai Xu, Kathryn A. Kinzler, Amanpreet Kaur +16 more
20150 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Lehmann×18
Invite
F. Lehmann — researcher profile on SciRah
V. A. Flørenes×16
Invite
V. A. Flørenes — researcher profile on SciRah
Juho J Miettinen×11
Invite
Juho J Miettinen — researcher profile on SciRah
N. Nupponen×11
Invite
N. Nupponen — researcher profile on SciRah

×9

Invite

C. Heckman — researcher profile on SciRah

Invite

B. Davidson — researcher profile on SciRah

Invite

M. Herlyn — researcher profile on SciRah

Maiju-Emilia Huppunen×7

Invite

Maiju-Emilia Huppunen — researcher profile on SciRah

Invite

K. Byrgazov — researcher profile on SciRah

Invite

M. Suvela — researcher profile on SciRah

Invite

R. Holm — researcher profile on SciRah

Invite

E. Emilsen — researcher profile on SciRah